'Vancomycin resistant' presentation slideshows

Vancomycin resistant - PowerPoint PPT Presentation

Section 15. Infection disease and Anti-infective drugs ( ???? ?????????? ) ????

Section 15. Infection disease and Anti-infective drugs ( ???? ?????????? ) ????

Section 15. Infection disease and Anti-infective drugs ( ???? ?????????? ) ????. content. Part 3. Macrolides( ????? ), Lincomycin( ????? ), and Vancomycin( ???? ) Part 4. Aminoglycosides( ????? ) and Polymyxins( ????? ) Part 5. Tetracyclines( ???? ) and Chloramphenicol( ??? )

★ ★ ★ ★ ★

1.55k views • 152 slides
NEWER MACROLIDES

NEWER MACROLIDES

NEWER MACROLIDES. Improved acid stability, tissue penetration. Broader spectrum of activity. ANTIMICROBIAL ACTIVITY. Most active against gram-positive cocci and bacilli. Mycoplasma , Legionella and Chlamydia. ANTIMICROBIAL ACTIVITY. Mycobacterium avium intracellulare (MAC). ABSORPTION.

★ ★ ★ ★ ★

1.28k views • 95 slides
The Challenges of Communicable Diseases

The Challenges of Communicable Diseases

The Challenges of Communicable Diseases. Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Malaysia. Global Leading causes of Death 2002. WHO 2004. Dr Margaret Chan Director-General, WHO 3 rd . April 2007.

★ ★ ★ ★ ★

658 views • 55 slides
MANAGEMENT OF SKIN AND SOFT TISSUE INFECTIONS

MANAGEMENT OF SKIN AND SOFT TISSUE INFECTIONS

MANAGEMENT OF SKIN AND SOFT TISSUE INFECTIONS. Jose A. Vazquez, M.D. Senior Staff Division of Infectious Disease Henry Ford Hospital Professor of Medicine Wayne State University. Skin and Soft Tissue Infections General Considerations. Primary vs. Secondary infections Portal of entry

★ ★ ★ ★ ★

1.08k views • 47 slides
ESKAPE from Pathogens

ESKAPE from Pathogens

ESKAPE from Pathogens

★ ★ ★ ★ ★

3.83k views • 46 slides
MACROLIDES, KETOLIDES, LINCOSAMIDES, OXAZOLIDINONES & 0THER ANTIBACTERIAL DRUGS

MACROLIDES, KETOLIDES, LINCOSAMIDES, OXAZOLIDINONES & 0THER ANTIBACTERIAL DRUGS

MACROLIDES, KETOLIDES, LINCOSAMIDES, OXAZOLIDINONES & 0THER ANTIBACTERIAL DRUGS. MACROLIDES. Means a multimembered lactone ring structure to which one or more deoxysugar molecules are attached Prototype is erythromycin

★ ★ ★ ★ ★

1.51k views • 41 slides
MICR 420

MICR 420

MICR 420. Emerging and Re-Emerging Infectious Diseases Lecture 3: Challenge of Antibiotic Resistance S. aureus (MRSA), E. faecalis (VRE), A. baumannii Dr. Nancy McQueen & Dr. Edith Porter. Challenge of antibiotic resistance S. aureus Methicillin resistance E. faecalis

★ ★ ★ ★ ★

449 views • 36 slides
Part4 Macrolides( ????? ), Lincomycin( ????? ), and Vancomycin( ???? )

Part4 Macrolides( ????? ), Lincomycin( ????? ), and Vancomycin( ???? )

Part4 Macrolides( ????? ), Lincomycin( ????? ), and Vancomycin( ???? ). Huifang Tang tanghuifang@zju.edu.cn. Macrolides. Part4-1 Macrolides. History 1952 Erythromycin( ??? ) 1970s Acetylspiramycin( ?????? ) Medecamycin( ???? ) josamycin( ???? )

★ ★ ★ ★ ★

807 views • 29 slides
Chapter 25

Chapter 25

Chapter 25. Care of Patients with Infection. Mrs. Kreisel MSN, RN NU130 Adult Health 1 Summer 2011. Definitions. Pathogen—any microorganism capable of producing disease Communicable—infection transmitted from person to person Pathogenicity—the ability to cause disease

★ ★ ★ ★ ★

501 views • 27 slides
ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA. THE TREATMENT.

★ ★ ★ ★ ★

262 views • 6 slides
Vancomycin-Resistant Enterococcus Faecium Infections Market Size, Share, Regional Outlook, Competitive Strategies And Fo

Vancomycin-Resistant Enterococcus Faecium Infections Market Size, Share, Regional Outlook, Competitive Strategies And Fo

This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections and special features on late-stage and discontinued projects.

★ ★ ★ ★ ★

337 views • 4 slides

View Vancomycin resistant PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Vancomycin resistant PowerPoint presentations. You can view or download Vancomycin resistant presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.